Wahab N R,Al-dujaili M N,AL-Khirsani H A H A A .2020 .The impact of increased body weight on left ventricular diastolic function. J. Adv. Pharm. Edu. Res, 10(1) : 150-157.
Keyhanazar K. .2020 .Evaluation of oocyte changes around dankhoras and drinkers at different weeks in poultry farms of Mahabad. J. Adv. Pharm. Edu. Res, 10(1) : 90-95.
Waggiallah H A. Hepcidin .2020 .As an Iron Regulator and Inflammatory Mediator in Several Clinical Conditions: Narrative. Int. J. Pharm. Phytopharm. Res, 11(3) : 164-170.
Nourmohammadi E,Nedaeinia R,Goli M,Hosseini Teshnizi S,Sarkarizi H,Sarkarizi K,Nedaeinia M,Faraji H M .2018 .Novel application of Nanotechnology in drug and Gene delivery: emphasis on Liposomes. Int. J. Pharm. Phytopharm. Res, 8(6) : 81-91.
Sood R,Bakashi R,Hegade VS,Kelly SM . .Diagnosis and management of hereditary haemochromatosis. 2013 Jun, 1(611) : 331-2.
Bacon BR .2012 .Hemochromatosis: discovery of the HFE gene. Missouri medicine, 109(2) : 133-6.
Bacon BR,Adams PC,Kowdley KV,Powell LW,Tavill AS .2011 .Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology (Baltimore, Md. , 54(1) : 328.
Phatak PD,Bonkovsky HL,Kowdley KV .2008 .Hereditary Hemochromatosis: Time for Targeted Screening. Annals of Internal Medicine, 149(4) : 200808190.
Adams PC,Reboussin DM,Barton JC,McLaren CE,Eckfeldt JH,McLaren GD,Dawkins FW,Acton RT,Harris EL,Gordeuk VR,Leiendecker-Foster C . .Hemochromatosis and iron-overload screening in a racially diverse population. 2005 Apr, 352(17) : 1769-78.
Allen KJ,Gurrin LC,Constantine CC,Osborne NJ,Delatycki MB,Nicoll AJ,McLaren CE,Bahlo M,Nisselle AE,Vulpe CD,Anderson GJ . .Iron-overload-related disease in HFE hereditary hemochromatosis. 2008 Jan, 17(3) : 221-30.
Adams P,Brissot P,Powell LW . .Part II. Expert Document. 2000 Sep, 8278(01) : 80874-6.
Zoller H,Henninger B .2016 .Pathogenesis, diagnosis and treatment of hemochromatosis. Digestive Diseases, 34(4) : 364-73.
Bardou-Jacquet E,Morcet J,Manet G,Lainé F,Perrin M,Jouanolle AM,Guyader D,Moirand R,Viel JF,Deugnier Y. .2014 .Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosis. 2015 Mar, 10(3) : 682-9.
Wood MJ,Powell LW,Ramm GA . .Environmental and genetic modifiers of the progression to fibrosis and cirrhosis in hemochromatosis. -11-122374., 1(9) : 4456-62.
De Gobbi M,Roetto A,Piperno A,Mariani R,Alberti F,Papanikolaou G,Politou M,Lockitch G,Girelli D,Fargion S,Cox TM .2002 .Natural history of juvenile haemochromatosis. British journal of haematology, 03509(4) : 2141-9.
Geller SA .2014 .Jan;5(1):7. Autopsy & case reports, 043 : .
Walton C,Kelly WF,Laing I,Bu'Lock DE I . .Endocrine abnormalities in idiopathic haemochromatosis. 1983 Jan, 1(1) : 99-110.
Kelly TM,EDWARDS CQ,MEIKLE AW . .Hypogonadism in hemochromatosis: reversal with iron depletion. 1984 Nov, 1(5) : 0003-32.
Adams PC,Barton JC. .2011 .A diagnostic approach to hyperferritinemia with a non-elevated transferrin saturation. 2011 Aug, 02(2) : 453-8.
Adams PC,Speechley M,Barton JC,McLaren CE,McLaren GD,Eckfeldt JH . .Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study. Hepatology, 55(6) : 1722-6.
Yang Q,McDonnell SM,Khoury MJ,Cono J,Parrish RG . .Hemochromatosis-associated mortality in the United States from 1979 to 1992: an analysis of multiple-cause mortality data. 1998 Dec, 1(11) : 2-199812011.
Niederau C,Strohmeyer G,Stremmel W. Epidemiology .1994 .clinical spectrum and prognosis of hemochromatosis. InProgress in Iron Research, : 31-302.
Schumacher HR . .Articular cartilage in the degenerative arthropathy of hemochromatosis. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, 25(12) : 1460-8.
Emery J,Rose P . .Hereditary haemochromatosis: never seen a case?. The British Journal of General Practice, 51(466) : 347.
Tavill AS .2001 .Diagnosis and management of hemochromatosis. Hepatology. 2001 May, 24783(5) : 1321-8.
Adams PC,Reboussin DM,Leiendecker-Foster C,Moses GC,McLaren GD,McLaren CE,Dawkins FW,Kasvosve I,Acton RT,Barton JC,Zaccaro D .2005 .Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101 168 participants in the Hemochromatosis and Iron Overload Screening (HEIRS) Study. 2005 Jun, 048371(6) : 1048-52.
Schmitt B,Golub RM,Green R . .Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: systematic review for the American College of Physicians. 2005 Oct, 4(7) : 200510040-36.
Pietrangelo A,Deugnier Y,Dooley J,Erhardt A,Zoller H,Safadi R. EASL .2010 .clinical practice guidelines for HFE hemochromatosis. 2010 Jul, 03(1) : 3-22.